Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study.

Por Steward, W. P., Scarffe, J. H., Austin, R., Bonnem, E., Thatcher, N., Morgenstern, G., Crowther, D.
Publicado em 1989

Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer.

Por Steward, W. P., Scarffe, J. H., Dirix, L. Y., Chang, J., Radford, J. A., Bonnem, E., Crowther, D.
Publicado em 1990

Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections--a phase I dose toxicity trial.

Por Gilleece, M. H., Scarffe, J. H., Ghosh, A., Heyworth, C. M., Bonnem, E., Testa, N., Stern, P., Dexter, T. M.
Publicado em 1992

Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex.

Por Hewitt, R G, Morse, G D, Lawrence, W D, Maliszewski, M L, Santora, J, Bartos, L, Bonnem, E, Poiesz, B
Publicado em 1993